Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 11327

Long Beach, CA 90813

Study Summary:

GSK1349572 is an experimental HIV treatment from the new integrase inhibitor class of antiretrovirals. This trial is comparing it to raltegravir - the only other drug currently approved in this class.

Participants in the trial must have genotypic or phenotypic resistance to at least one member of each of at least two antiretroviral therapy (ART) drug classes.

Qualified Participants Must:

• Be at least 18 years of age Have demonstrated resistance to multiple HIV drugs and/or drug classes

Qualified Participants May Receive:

If you are committed to exploring options, you may qualify to receive up to 48 weeks of investigational study treatment and study related care at no cost. No insurance is required.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.